leflunomide has been researched along with Leishmaniasis, American in 1 studies
Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.
Excerpt | Relevance | Reference |
---|---|---|
"Leflunomide has been reported as an immunomodulating agent which acts on a variety of cells including T- and B-lymphocytes." | 1.29 | Protective effect of leflunomide on the natural course of Leishmania major-induced disease in genetically susceptible BALB/c mice. ( Asmuss, PA; Humborg, C; Röllinghoff, M; Solbach, W; Zimmermann, S, 1995) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Solbach, W | 1 |
Asmuss, PA | 1 |
Zimmermann, S | 1 |
Humborg, C | 1 |
Röllinghoff, M | 1 |
1 other study available for leflunomide and Leishmaniasis, American
Article | Year |
---|---|
Protective effect of leflunomide on the natural course of Leishmania major-induced disease in genetically susceptible BALB/c mice.
Topics: Animals; Antiparasitic Agents; Antiprotozoal Agents; Female; Genetic Predisposition to Disease; Immu | 1995 |